Business
Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms
Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ to treat patients with atrial fibrillation (AFib). Following the new approval, the first successful commercial cases using TactiFlex Duo in the European Union were completed this week.
About this update from Abbott Laboratories
[{"type":"list","items":[{"val":[{"type":"text","content":"Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™, is designed with dual-energy to treat atrial fibrillation patients with the most challenging cases","length":167,"tagName":"p"}]},{"val":[{"type":"text","content":"It can deliver both radiofrequency energy and pulsed field ablation (PFA) energy during procedures to target and treat an irregular heart rhythm","length":149,"tagName":"p"}]},{"val":[{"type":"text","content":"The availability of TactiFlex Duo in Europe adds a dual-energy, focal ablation catheter to Abbott's growing PFA portfolio, following the company's Volt PFA System approvals in the U.S. and Europe last year","length":218,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":534,"olType":false},{"type":"text","content":"ABBOTT PARK, Ill., Jan. 20, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ to treat patients with atrial fibrillation (AFib). Following the new approval, the first successful commercial cases using TactiFlex Duo in the European Union were completed this week.","length":370,"tagName":"p"},{"type":"text","content":"Abbott's TactiFlex Duo Catheter is the latest advancement in the company's pulsed field ablation (PFA) technology portfolio. An effective cardiac ablation – a minimally invasive procedure to stop an irregular heart rhythm – relies on the quality of the scars (lesions) created by a catheter to stop the source of an arrhythmia. TactiFlex Duo is designed to deliver tailored therapy lesions in two ways: radiofrequency energy (uses heat to destroy tissue responsible for erratic heart signals), and pulsed field ablation energy (uses high energy electrical pulses to destroy the cells causing abnormal heart rhythms, which can reduce the risk of damaging adjacent tissue in patients with complex disease or anatomy).","length":723,"tagName":"p"},{"type":"text","content":""TactiFlex Duo's most unique feature is its dual options that allow physicians to seamlessly switch treatment during a procedure based on the patient's personalized needs and anatomy," said Prof. Isabel Deisenhofer, M.D., head of the department of Electrophysiology at the German Heart Center Munich in Germany, and one of the...